ahlam1399
09-04-2015, 03:13 PM
**vartis wins EU approval for multiple myeloma drug Farydak
ZURICH (Reuters) - **vartis AG said on Friday it received European Union approval for Farydak, a treatment for multiple myeloma that the company said gives new options for adult patients whose disease has progressed following standard therapy.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4991c021/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KLw17evuS7s:KZvudc5QXLo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KLw17evuS7s:KZvudc5QXLo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KLw17evuS7s
ZURICH (Reuters) - **vartis AG said on Friday it received European Union approval for Farydak, a treatment for multiple myeloma that the company said gives new options for adult patients whose disease has progressed following standard therapy.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4991c021/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KLw17evuS7s:KZvudc5QXLo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KLw17evuS7s:KZvudc5QXLo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KLw17evuS7s:KZvudc5QXLo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KLw17evuS7s